Orentas RJ
ORCID: 0000-0002-6310-3467
· 1 paper in corpus
2012
Technological advances now allow us to rapidly produce CARs and other antibody-derived therapeutics targeting cell surface receptors. To maximize the potential of these new technologies, relevant extracellular targets must be identified. Th…